Skip to main navigation Skip to search Skip to main content

Effect of red blood cells from patients with sickle cell disease on platelet factor 3 release

  • SUNY Buffalo

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Red cells from two SS genotype and two SA genotype patients were sampled. When the samples were deoxygenated and mixed with platelet‐rich plasma, they caused the release of platelet factor 3 as recorded in a coagulometer. This phenomenon was not present in control blood samples from normal individuals. Membrane changes in abnormal red cells during hypoxia may be responsible in part for platelet activation and its role in vasoocclusive crisis. Vasoocclusive crisis could be prevented by increasing the red cell membrane fluidity and inhibiting the platelet aggregation with pentoxifylline. © 1992 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)149-150
Number of pages2
JournalAmerican Journal of Hematology
Volume40
Issue number2
DOIs
StatePublished - Jun 1992

Keywords

  • pentoxifylline
  • platelet aggregation
  • vasoocclusive crisis

Fingerprint

Dive into the research topics of 'Effect of red blood cells from patients with sickle cell disease on platelet factor 3 release'. Together they form a unique fingerprint.

Cite this